U.S. Capital Markets Stock News

NYSE:MGM
NYSE:MGMHospitality

A Look At MGM Resorts (MGM) Valuation After Earnings Beat BetMGM Profitability And Record Macau EBITDAR

MGM Resorts International (MGM) is back in focus after posting fourth quarter earnings that topped analyst expectations, alongside a profitable year for its BetMGM joint venture and record EBITDAR in Macau. See our latest analysis for MGM Resorts International. The latest earnings beat and BetMGM profitability seem to have reset sentiment, with the 1 day share price return of 3.34% and 7 day share price return of 11.78% contributing to a 90 day share price return of 14.12%. However, the 3...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Will Broadcom's (AVGO) Wi‑Fi 8 Edge Push and Custom AI Chips Reshape Its Infrastructure Narrative

Earlier this week, Broadcom announced the industry's first Wi‑Fi 8 access point and switch solution built on its new BCM49438 APU and Trident X3+ BCM56390 Ethernet switch, aiming to support AI-ready enterprise networks with unified security, analytics, and multi-gigabit performance. An interesting angle is that this enterprise Wi‑Fi 8 launch sits alongside surging AI data-center demand from hyperscalers like Alphabet and Amazon, positioning Broadcom across both cloud AI accelerators and the...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

Assessing Perella Weinberg Partners (PWP) Valuation After A Strong Multi‑Week Share Price Rally

Why Perella Weinberg Partners Has Caught Investor Attention Perella Weinberg Partners (PWP) has been drawing fresh interest from investors after a strong recent share price move, with the stock up around 8% over the past week and about 23% over the past month. See our latest analysis for Perella Weinberg Partners. The latest 1 day share price return of 8.0% continues a run that has lifted the 30 day share price return to 23.4% and the year to date share price return to 32.5%. The 3 year total...
NYSE:EAT
NYSE:EATHospitality

Has The Market Fully Reflected Brinker International (EAT) After Strong Multi‑Year Share Gains

If you are wondering whether Brinker International's current share price still offers value, this article will walk through what the numbers say and how that lines up with the story around the stock. The shares most recently closed at US$168.93, with returns of 7.1% over the last 7 days, 5.6% over the last 30 days, 11.5% year to date, a 1.8% decline over the past year and a very large 3 year gain alongside a 152.9% 5 year return. Recent market attention has been shaped by ongoing updates...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands Resets Supply Chain And Pricing As Shares Look Undervalued

Newell Brands has reduced its sourcing exposure to China, shifting its supply chain footprint. The company is rolling out automation and AI tools to improve productivity across its global operations. Management is resetting pricing after some customers pushed back on previous price levels. Newell Brands recorded a substantial impairment of acquired intangible assets in its latest quarter. Newell Brands (NasdaqGS:NWL) is making these changes while its shares trade at $4.63. The stock is up...
NYSE:MPT
NYSE:MPTHealth Care REITs

Is Medical Properties Trust (MPT) Starting A Recovery After Recent Balance Sheet And Asset Moves?

If you are wondering whether Medical Properties Trust at around US$5.36 is a potential bargain or a value trap, you are not alone. A closer look at its valuation can help you frame that question more clearly. The stock is up 6.8% over the last 7 days and 5.5% year to date. That sits against a 20.0% return over 1 year and much larger declines of 41.4% over 3 years and 64.1% over 5 years. Recent news around Medical Properties Trust has largely focused on its balance sheet strength, asset...
NYSE:BE
NYSE:BEElectrical

Is Bloom Energy (BE) Pricing Reflect Its Surge After A Strong Year Of Returns

If you are trying to work out whether Bloom Energy's share price makes sense today, you first need to understand what the current market price is really implying about the business. The stock has had a mixed recent run, with a 5.5% decline over the last 7 days, a 6.7% gain over 30 days, a 44.9% return year to date, and a very large 1 year return that sits between 4x and 5x. These moves sit against a backdrop of ongoing investor attention on fuel cell and clean energy names. Bloom Energy...
NYSE:HSY
NYSE:HSYFood

Is It Too Late To Consider Hershey (HSY) After A 54% One-Year Surge?

If you are wondering whether Hershey at around US$231.53 is still reasonable value after a strong run, this article walks through the key numbers that matter. The stock has recent returns of 18.9% over 7 days, 22.5% over 30 days, 26.9% year to date and 54.3% over 1 year, which naturally raises questions about how the current price lines up with the fundamentals. Recent news coverage has focused on Hershey as a long established consumer brand, with attention on how staple food companies are...
NYSE:BHC
NYSE:BHCPharmaceuticals

Is Bausch Health (BHC) Pricing Reflect Long Term Potential After 81% Five Year Share Slump

If you are wondering whether Bausch Health Companies at around US$5.88 is a bargain or a value trap, you are not alone. This article is built to help you weigh that up with a clear look at the numbers. The stock has seen mixed recent returns, with a 2.4% gain over the last 7 days, a 20.6% decline over the past month, and returns of 18.4% lower year to date and 8.8% lower over the past year, set against a much steeper 81.2% decline over five years. Recent news coverage around Bausch Health...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

What TMC the metals (TMC)'s New U.S. Backing and Korea Zinc Funding Means For Shareholders

Recent news highlighted how U.S. government initiatives such as Project Vault and possible Defense Production Act support are boosting attention on TMC The Metals Company’s deep-sea polymetallic nodule mining plans, alongside new funding including a US$37 million direct investment and a US$85.2 million strategic commitment from Korea Zinc. This combination of policy momentum and fresh capital underscores TMC’s role in efforts to secure alternative battery metal supplies and reduce reliance...
NYSE:DV
NYSE:DVMedia

A Look At DoubleVerify Holdings (DV) Valuation As AI Disruption Fears Pressure Enterprise Software Stocks

DoubleVerify Holdings (DV) came under pressure after new generative AI models from Anthropic and OpenAI showed they can automate complex software auditing and code management, prompting investors to reassess potential long term demand for some enterprise software offerings. See our latest analysis for DoubleVerify Holdings. Beyond the latest AI concerns, DoubleVerify’s share price has been weak for some time, with a 7 day share price return of 13.68% and a 1 year total shareholder return...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Reassessing Microsoft (MSFT) After Recent Share Price Pullback

If you are wondering whether Microsoft is fairly priced or if the recent pullback has improved the value on offer, you are not alone. This article is aimed directly at that question. Microsoft's share price last closed at US$401.14, with returns of a 6.8% decline over 7 days, a 16.3% decline over 30 days, a 15.2% decline year to date and a 1.4% decline over 1 year, while the 3 year and 5 year returns sit at 56.1% and 70.6% respectively. These moves are occurring against a backdrop of ongoing...
NYSE:AM
NYSE:AMOil and Gas

Is Antero Midstream (AM) Pricing Reflect Its Strong Multi‑Year Share Price Performance

Wondering if Antero Midstream at around US$19.18 is offering fair value or if the market is missing something? This article walks through the key signals that matter for you. The stock has recent returns of 1.9% over 7 days, 10.8% over 30 days, 6.9% year to date, 25.4% over 1 year, 116.4% over 3 years and 205.3% over 5 years, which gives useful context before you weigh up what you are paying today. Recent attention on Antero Midstream has focused on its role as an energy infrastructure...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz Pharmaceuticals (JAZZ) Valuation After HERIZON GEA Trial Upside And Planned 2026 sBLA Filing

Jazz Pharmaceuticals (NasdaqGS:JAZZ) is back in focus after practice changing HERIZON GEA trial results and plans to file a supplemental Biologics License Application in 2026 for first line gastroesophageal adenocarcinoma therapies. See our latest analysis for Jazz Pharmaceuticals. Investors have responded positively to the HERIZON GEA update, with a 24.26% 90 day share price return from Jazz Pharmaceuticals and a 37.58% 1 year total shareholder return, suggesting momentum has picked up...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Assessing Relay Therapeutics (RLAY) Valuation After Recent Share Price Momentum And Price To Book Discount

Why Relay Therapeutics (RLAY) is on investors’ radar Relay Therapeutics (RLAY) has drawn attention after a strong stretch of share price performance, including a positive move over the past month and an even stronger gain in the past 3 months. See our latest analysis for Relay Therapeutics. At a latest share price of $8.92, Relay Therapeutics has seen momentum build, with a 1 day share price return of 9.45% and a 90 day share price return of 44.57%, while the 1 year total shareholder return...
NYSE:ZGN
NYSE:ZGNLuxury

Assessing Ermenegildo Zegna (ZGN) Valuation After Q4 Growth Acceleration And UBS Upgrade

Ermenegildo Zegna (ZGN) is back in focus after reporting unaudited fourth quarter and full year 2025 revenues and receiving an upgrade from UBS, which has drawn fresh attention to the company’s recent operating trends. See our latest analysis for Ermenegildo Zegna. The latest unaudited revenue update and the UBS upgrade have come alongside a sharp rebound in sentiment, with a 7 day share price return of 19.56% and a 1 year total shareholder return of 20.47%. This suggests momentum has...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Why Popular (BPOP) Is Up 9.3% After Strong 2025 Earnings And Share Buybacks

Popular, Inc. recently reported full-year 2025 results showing higher net interest income of US$2,541.2 million and net income of US$833.16 million, and it also disclosed lower quarterly net charge-offs alongside ongoing preferred and trust preferred dividend payments. The company further reinforced shareholder returns by completing a share repurchase of 1,847,274 shares for US$218.83 million while continuing regular income distributions on its hybrid securities. With earnings strength and...